This is a collaboration between the British Society of Gastroenterology (BSG) and the
European Society of Gastrointestinal Endoscopy (ESGE), and is a scheduled update of their …

1 ESGE recommends against diagnostic/therapeutic papillectomy when adenoma is not
proven. Strong recommendation, low quality evidence. 2 ESGE recommends endoscopic …

Ampullary lesions (ALs) can be treated by endoscopic (EA) or surgical ampullectomy (SA) or
pancreaticoduodenectomy (PD). However, EA carries significant risk of incomplete resection …

Background Endoscopic papillectomy is a viable therapy in ampullary lesions. Prior studies
have reported on outcomes of sporadic ampullary lesions, and only small cohort studies …

ABSTRACT Background and Aims Consensus regarding an optimal algorithm for
endoscopic treatment of papillary adenomas has not been established. We aimed to assess …

Background and Aims Ampullary adenomas (AAs), common in familial adenomatous
polyposis (FAP), are precursors to ampullary carcinoma. We assessed the natural history of …

BACKGROUND Ampullary adenoma is a rare premalignant lesion, but its incidence is
increasing. Endoscopic papillectomy has become the first treatment of choice for ampullary …

Objectives There are few reports on the long‐term prognosis of papillary tumors after
endoscopic papillectomy. Here, we report a retrospective study of the therapeutic effects …

Background Ampullary lesions are rare and can be locally treated either with endoscopic
papillectomy or transduodenal surgical ampullectomy. Management of local recurrence after …

Background: Endoscopic papillectomy is a minimally invasive treatment for benign tumors of
the ampulla of Vater or early ampullary carcinoma. However, reported recurrence rates are …